Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryant Lim

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Neurobiology of Aging|August 17, 2021
CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementiaBryant Lim, Gøril Rolfseng Grøntvedt, Pradeepthi Bathala, et al.
Neuroscience Letters|May 26, 2020
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's diseaseBryant Lim, Christopher Fowler, Qiao-Xin Li, et al.
F1000Research|September 8, 2018
Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progressionIlijana Begcevic, Magda Tsolaki, Davor Brinc, et al.
Journal of the American Geriatrics Society|May 23, 2026
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection: A Multicentre, Pragmatic, Randomized Trial-Vanguard ResultsMichael Fralick, Nathan M Stall, Katarina Zorcic, et al.
Cell Chemical Biology|August 10, 2022
Discovery of compounds that reactivate p53 mutants in vitro and in vivoGeetha Durairaj, Özlem Demir, Bryant Lim, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neurobiology of Aging|August 17, 2021
CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer's disease dementiaBryant Lim, Gøril Rolfseng Grøntvedt, Pradeepthi Bathala, et al.
Neuroscience Letters|May 26, 2020
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's diseaseBryant Lim, Christopher Fowler, Qiao-Xin Li, et al.
F1000Research|September 8, 2018
Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progressionIlijana Begcevic, Magda Tsolaki, Davor Brinc, et al.
Journal of the American Geriatrics Society|May 23, 2026
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection: A Multicentre, Pragmatic, Randomized Trial-Vanguard ResultsMichael Fralick, Nathan M Stall, Katarina Zorcic, et al.
Cell Chemical Biology|August 10, 2022
Discovery of compounds that reactivate p53 mutants in vitro and in vivoGeetha Durairaj, Özlem Demir, Bryant Lim, et al.
Pageof 2